
Omar Hameed Butt, MD, PhD
Cancer (Oncology), Medical Oncology
Specializes in
Brain tumors and other primary central nervous system cancers
Appointments
- Gary C. Werths Building at Siteman Cancer Center4500 Forest Park AvenueSt. Louis, MO 63108314-747-1171
Hospital Affiliations
This provider offers inpatient care at these hospitals.
- Barnes-Jewish Hospital
Experience
Board Certifications
- American Board of Psychiatry and Neurology
Academic Title(s)
Assistant Professor, MedicineDivision of Oncology
Publications & Research
View research profile »Education
2022 Washington University School of Medicine, St. Louis, MO
2020 Washington University School of Medicine, St. Louis, MO
2016 University of Pennsylvania, Philadelphia
2014 University of Pennsylvania, Philadelphia
2007 Johns Hopkins University, Baltimore, MD
2007 Johns Hopkins University, Baltimore, MD
- Novocure
- Consulting/Advisory Board: $20,000 - $39,999
- Reporting Date: 05/01/2026
Washington University and its physicians and health professionals are committed to ensuring integrity and objectivity in medical decision-making. Some of our physicians and health professionals work collaboratively with pharmaceutical, medical device or other medical care related companies to develop innovative ideas and products that can improve health care delivery and clinical outcomes for patients. In some instances, our physicians and health professionals have an ownership or potential ownership interest in a commercial company; and/or are paid by a commercial company to provide advice on product design or to speak about the use of medications, devices, equipment or procedures. These payments may include: a) compensation for consulting and speaking engagements, b) equity, and/or c) royalties for products invented by our faculty. Any payments to Washington University physicians or health professionals must be based on tangible services and may not exceed fair market value for their work. In addition to disclosure on this website, physicians and health professionals earning more than $10,000 per year must disclose their corporate financial relationship in writing to patients when prescribing or using that company's products.
Is this your profile? Request an edit »